Inhibitors and Probes of HIV-1 Cell Fusion
$507,187Z01FY2008DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 18667502Paper 18183018Paper 17963357Paper 17901336Paper 17898046Paper 17010381Paper 16952190Paper 16930043Paper 16908186Paper 16216270Paper 16156659Paper 15937331Paper 15828842Paper 15332849Paper 15332836Paper 15209519Paper 15203162Paper 15165858Paper 14640525Paper 12757730Paper 12713335Paper 12654905Paper 12538025Paper 12443092Paper 12270721Paper 12161164Paper 12027767Paper 11929223Paper 11916396Paper 11859089Paper 11846592Paper 11591348Paper 11457139Paper 11456652Paper 11418583Paper 11388862
Abstract
The Natural Products Chemistry Section, LBC, NIDDK has several ongoing projects whose long term aim is to identify and design inhibitors and probes of HIV-1 Envelope-mediated cell fusion. These include the design and development of new gp41-derived peptides and proteins that have dual functions as inhibitors and immunogens, discovery and high resolution structural characterization of new carbohydrate binding proteins that potently inhibit HIV-1 Entry through carbohydrate-mediated interactions with gp120/gp41, discovery of natural product inhibitors of HIV-1 fusion, and structural and mechanistic studies of HIV-1 Envelope - coreceptor interactions.
View original record on NIH RePORTER →